We would love to hear your thoughts about our site and services, please take our survey here.
Don't worry about humble Sheppy - he's predicting 170 by end of March. One of the biggest rampers on here. He was also chatting about patience, so for a man as humble as him, 2 years is but a heart beat
No such thing as FUD on here - FDA APPROVAL ON THE WAY!!! 170p inbound - thanks Sheppy!!!
All of them spot on!!!! Read them back - today is the start of the re-rate. Thanks Timster, you have your finger on the pulse and can read markets brilliantly. Your confidence here is all I need to add more - BUY BUY BUY!!!!
I’ve just been looking and today between 9 and 10 am 665,597 traded and between 10 and 11am 627,279 traded. The hourly average has only been running about 120,000.
Someone is confident…. It’s me! Doubling my £500k. New due soon, fire up the rockets folks, we’re on the way to the moon!
Thanks Andrew! You're the second best! - just behind sheppy.
Anyone else buying the dip??? With all the progress that's been made, this is the cheapest the share price has ever been. I think I'll write a 10 page document in the third person to celebrate.
Absolutely right - and the journey starts NOW!! I've just licked my window clean and got my crayons out and it turns out this is the bottom of Elliot's wave 4. According to Fibonacci, who I met in McDonald's over a filet-o-fish, he reckons it'll soon fire up to £3.40 and that's before the stellar RNS lands... ROCKET TIME BABY!!!
Worth pointing out that given the significance of the preCISION platform, those relevant to dealmaking will be fully aware of this too.
We know ‘lots’ want preCISION since spring 2023 (or earlier).
Unbelievably exciting times now. Any day now - whoosh 💥🙌
That’s why we’ve not heard anything. It’s the only possibility. They’ve signed NDAs and have been asked not to share the amazing data in detail. I think Novartis have already made an off the record offer. Buy the dip! You’ll regret it if you don’t. For chart fans, we’re at the bottom of a channel and the RSI is low - it’s definitely going to rise from here
This is guaranteed to fly and very soon. They're sat on incredible data proving the platform works and they've hired Simon to do a multitude of deals worth millions up front and %s that will eventually be worth billions. AACR will see them present 1a data and at that point big pharma will be forming an orderly queue. I wouldn't be surprised if one of them breaks cover and offers at least £50 a share, where the take over price will be once the inevitable bidding war starts is anyone's guess. I've never been in a share with this much imminent potential. Easy 50+ bags!! WWTBOOTOOTNextFewWeeks!!!!
I was looking this morning and wondering how they have the energy to relentlessly spam the same old stuff every single day several times. TTB is on something. Not sure if they’re trying to convince themselves. Chief Victoria sponge eater Myles predicted a deal within 3 weeks about 2 months ago.
It’d be a lot more efficient if they just named their target price then we could save all the nonsense. Everyone could sell and buy back at the target price. Nice, simple, straightforward market manipulation. Elliot would be proud.
CJ, if you’re unhappy, sell up. Genuinely. No point letting it get to you. However, word of warning, fomo is worse, you’ll never stop looking back. Aim owns you now, you’re trapped forever….
A tremendous success, many back to back green boxes. Well done to everyone involved, they couldn't have done it if you'd just binned or reported and ignored them. Great to see some new faces too, plenty strength in depth when it comes to being a disruptive twat. TW must be brimming with pride.
That's what has been communicated. They're using the additional study to optimise phase 2. It's an expedited approach versus the original 1b which was looking pointless given the efficacy that had already been seen. All setting up a pivotal phase 2 and all emerging data could lead to accelerated approvals at any time based on surviving patients. They're getting on with it and with the new leadership team in a much better way than previously - focussing on commercial outcomes for the platform asap.